Ozempic and Wegovy: Beyond Diabetes Management – New Findings on Brain Health Benefits
Recent research by Oxford University, supported by the NIHR Oxford Health Biomedical Research Centre and the Medical Research Council, has uncovered that semaglutide, the active ingredient in Ozempic and Wegovy, may offer benefits beyond managing type 2 diabetes and obesity. The study, published in eClinicalMedicine, indicates that semaglutide does not negatively impact brain health. Instead,…
